Patents by Inventor Timothy Robertson
Timothy Robertson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12099353Abstract: Systems, methods, and other embodiments described herein relate to controlling a trailer without the presence of a physical connection. In one embodiment, a method includes in response to receiving a signal to initiate hitchless maneuvering of a trailer separately from a controlling vehicle, acquiring control inputs to maneuver the trailer from an input device within the controlling vehicle. The method includes communicating, from the controlling vehicle to the trailer, the control inputs to maneuver the trailer. The method includes in response to receiving feedback from the trailer indicating the trailer is within a requested position, sending a control signal to stop the trailer.Type: GrantFiled: January 27, 2022Date of Patent: September 24, 2024Assignee: Toyota Motor Engineering & Manufacturing North America, Inc.Inventors: Gregg J. Overfield, Paul Timothy Fanson, Derek S. Caveney, Mehmet Ali Guney, Stephen L Robertson, Miles J. Johnson
-
Patent number: 11825993Abstract: Spindles and cover assemblies for dispensing sheet product for use with coreless sheet product rolls. The spindle may include a hollow cylindrical body, which may have an elongated channel in a sidewall; a rod which extends partially out of the body; and a spring disposed within the body in biasing contact with the rod. The rod may include a flexible tab matingly engaged within the channel, permitting the rod to translate within the hollow cylindrical body without falling out. The hollow cylindrical body may have an end with an opening bounded by an inward facing ledge, and the rod may include a radial ledge, such that the rod can translate within the body but cannot fall out due to interference between the inward facing ledge and the radial ledge. The spindle may include a friction hub disposed about and rotatable around the hollow cylindrical body between ends of the body.Type: GrantFiled: July 9, 2019Date of Patent: November 28, 2023Assignee: GPCP IP Holdings LLCInventors: Timothy Robertson, Aaron Sinclair, Steven Mattheeussen, Todd Schuelke, Samuel Bruenger, John Grosz
-
Patent number: 11741771Abstract: A target authentication device includes an electrode to detect an electrical signal associated with a user of the device. The electrical signal represents an authentication code for the device. An authentication receiver module is coupled to the electrode. The module receives the electrical signal from the electrode and determines whether the electrical signal matches a predetermined criterion to authenticate the identity of the user based on the electrical signal. An authentication module is also disclosed. The authentication module includes one electrode to couple an electrical signal associated with a user to a user of a target authentication device, the electrical signal represents an authentication code for the device. An authentication transmission module is coupled to the electrode. The authentication transmission module transmits the electrical signal from the electrode. A method of authenticating the identity of a user of a target authentication device also is disclosed.Type: GrantFiled: September 24, 2021Date of Patent: August 29, 2023Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Timothy Robertson, George Savage, Benedict Costello, David O'Reilly
-
Publication number: 20230157570Abstract: Power sources that enable in-body devices, such as implantable and ingestible devices, are provided. Aspects of the in-body power sources of the invention include a solid support, a first high surface area electrode and a second electrode. Embodiments of the in-power sources are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the power sources of the invention.Type: ApplicationFiled: August 25, 2022Publication date: May 25, 2023Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Hooman Hafezi, Timothy Robertson, Eric Snyder, Brad Cozad
-
Patent number: 11612321Abstract: Transbody communication systems employing communication channels are provided. Various aspects include, for example, an in vivo transmitter to transmit an encoded signal; a transbody functionality module to facilitate communication of the encoded signal; and a receiver to receive the encoded signal. Methods and apparatus are also provided.Type: GrantFiled: February 12, 2020Date of Patent: March 28, 2023Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Timothy Robertson, Kenneth C. Crandall, Lawrence W. Arne
-
Publication number: 20220346664Abstract: Methods, devices and systems for acquiring information useful to support a patient in implementing and adhering to a medically prescribed therapy plan are provided. The therapy may incorporate biofeedback methods and/or personalized therapy aspects. A method includes steps of receiving, by a receiving device, biometric information associated with an ingestible event marker; analyzing, by a computing device having a microprocessor configured to perform a biometric information analysis, the biometric information; and determining a therapeutic recommendation at least partly on the basis of the analysis and/or integrating biofeedback techniques into patient therapy or activity. A system includes a biometric information module to receive biometric information associated with an ingestible event marker; an analysis module to analyze the biometric information; and a determination module to optionally determine and communicate a therapeutic recommendation at least partly on the basis of the analysis.Type: ApplicationFiled: July 14, 2022Publication date: November 3, 2022Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Marc JENSEN, Robert LEICHNER, Patrick BEAULIEU, Kityee AU-YEUNG, Lawrence ARNE, Mark ZDEBLICK, Andrew THOMPSON, George SAVAGE, Timothy ROBERTSON, Yashar BEHZADI
-
Publication number: 20220323364Abstract: Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.Type: ApplicationFiled: May 10, 2022Publication date: October 13, 2022Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
-
Patent number: 11464423Abstract: Power sources that enable in-body devices, such as implantable and ingestible devices, are provided. Aspects of the in-body power sources of the invention include a solid support, a first high surface area electrode and a second electrode. Embodiments of the in-power sources are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the power sources of the invention.Type: GrantFiled: January 22, 2015Date of Patent: October 11, 2022Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Hooman Hafezi, Timothy Robertson, Eric Snyder, Brad Cozad
-
Publication number: 20220189606Abstract: The ingestible event marker data framework provides a uniform, comprehensive framework to enable various functions and utilities related to ingestible event marker data (IEM data). The functions and utilities include data and/or information having an aspect of data derived from, collected by, aggregated by, or otherwise associated with, an ingestion event.Type: ApplicationFiled: November 29, 2021Publication date: June 16, 2022Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: David O'Reilly, Erika Karplus, Andrew Thompson, George Savage, Mark Zdeblick, Timothy Robertson, Lawrence Arne, Yashar Behzadi, Gregory Moon, Patrick Beaulieu
-
Patent number: 11357730Abstract: Apparatuses for use with a pharmaceutically acceptable carrier. The apparatus can include a partial power source, which in turn includes electrodes or materials that are configured to generate an electrical potential upon contacting or being exposed to an ionic solution. The apparatus can further include a circuit electrically or communicatively coupled to the partial power source. The circuit can generate various types of signals, such as RF signals, when powered by the partial power source. The circuit is stably fittable to the pharmaceutically acceptable carrier. The apparatus can further include a barrier, a protective layer, or a membrane that isolates the electrodes or materials from the ionic solution and is configured to be dissolved by the ionic solution.Type: GrantFiled: December 28, 2018Date of Patent: June 14, 2022Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Hooman Hafezi, Timothy Robertson, Olivier Colliou, Mark Zdeblick
-
Publication number: 20220116124Abstract: The present disclosure includes ingestible devices. In some examples, an ingestible device is presented that includes a framework, a control device secured to the framework, and a partial power source. The partial power source may include a first digestible material secured to the framework and electrically coupled to the control device, and a second digestible material electrically isolated from and dissimilar to the first digestible material, electrically coupled to the control device, and secured to the framework. The partial power source may be configured to provide power to the control device when the first and second digestible materials come in contact with a conductive fluid. The control device, after being provided power by the first and second digestible materials, may be configured to alter conductance between the first and second digestible materials to produce a current signature through the conductive fluid that is detectable by a receiver.Type: ApplicationFiled: May 20, 2021Publication date: April 14, 2022Applicant: OTSUKA PHARMACEUTICALInventors: Mark ZDEBLICK, Timothy ROBERTSON, Aleksandr PIKELNY, Hooman HAFEZI
-
Publication number: 20220079394Abstract: Disclosed are various examples of automated dispensers to dispense consumable products, such as paper towels, gels, liquids, gases, aerosols, foams, and other consumables. Automated dispensers can operate in various modes. Examples of the disclosure can utilize a dispense profile to adjust the speed at which consumable products are dispensed.Type: ApplicationFiled: September 7, 2021Publication date: March 17, 2022Inventors: David Warren Murphy, Brian S. Borke, Ryan A. Goltz, Timothy A. Robertson, Philip R. Walker
-
Publication number: 20220061693Abstract: Ingestible event markers having high reliability are provided. Aspects of the ingestible event markers include a support, a control circuit, a first electrochemical material, a second electrochemical material and a membrane. In addition, the ingestible event markers may include one or more components that impart high reliability to the ingestible event marker. Further, the ingestible event markers may include an active agent. In some aspects, the active agent, such as a pharmaceutically active agent or a diagnostic agent may be associated with the membrane.Type: ApplicationFiled: September 10, 2021Publication date: March 3, 2022Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Hooman HAFEZI, Kit Yee AU-YEUNG, Robert DUCK, Maria HOLEN, Timothy ROBERTSON, Benedict COSTELLO
-
Publication number: 20220012969Abstract: A target authentication device includes an electrode to detect an electrical signal associated with a user of the device. The electrical signal represents an authentication code for the device. An authentication receiver module is coupled to the electrode. The module receives the electrical signal from the electrode and determines whether the electrical signal matches a predetermined criterion to authenticate the identity of the user based on the electrical signal. An authentication module is also disclosed. The authentication module includes one electrode to couple an electrical signal associated with a user to a user of a target authentication device, the electrical signal represents an authentication code for the device. An authentication transmission module is coupled to the electrode. The authentication transmission module transmits the electrical signal from the electrode. A method of authenticating the identity of a user of a target authentication device also is disclosed.Type: ApplicationFiled: September 24, 2021Publication date: January 13, 2022Applicant: OTSUKA PHARMACEUTICAL CO. LTD.Inventors: Timothy Robertson, George Savage, Benedict Costello, David O'reilly
-
Patent number: 11217342Abstract: The ingestible event marker data framework provides a uniform, comprehensive framework to enable various functions and utilities related to ingestible event marker data (IEM data). The functions and utilities include data and/or information having an aspect of data derived from, collected by, aggregated by, or otherwise associated with, an ingestion event.Type: GrantFiled: April 26, 2017Date of Patent: January 4, 2022Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: David O'Reilly, Erika Karplus, Andrew Thompson, George Savage, Mark Zdeblick, Timothy Robertson, Lawrence Arne, Yashar Behzadi, Gregory Moon, Patrick Beaulieu
-
Patent number: 11173290Abstract: The present invention discloses multiple approaches to preventing the capsule walls and other material from interfering with the performance of an electronic device once the device is activated by surrounding fluid. In accordance with the teachings of the present invention, a miniature ingestible device (MID) may be created using excipients and films. The MID, in accordance with various aspects of the present invention, will have a coating or laminating surrounding an electronic device and separating and isolating the device from the pharmaceutical product or drug within the capsule once the capsule is ingested as well as from the capsule itself as the capsule walls begin to collapse during the disintegration process.Type: GrantFiled: February 1, 2019Date of Patent: November 16, 2021Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Timothy Robertson, Hooman Hafezi, Raymond Schmidt
-
Patent number: 11158149Abstract: A target authentication device includes an electrode to detect an electrical signal associated with a user of the device. The electrical signal represents an authentication code for the device. An authentication receiver module is coupled to the electrode. The module receives the electrical signal from the electrode and determines whether the electrical signal matches a predetermined criterion to authenticate the identity of the user based on the electrical signal. An authentication module is also disclosed. The authentication module includes one electrode to couple an electrical signal associated with a user to a user of a target authentication device, the electrical signal represents an authentication code for the device. An authentication transmission module is coupled to the electrode. The authentication transmission module transmits the electrical signal from the electrode. A method of authenticating the identity of a user of a target authentication device also is disclosed.Type: GrantFiled: May 11, 2017Date of Patent: October 26, 2021Assignee: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Timothy Robertson, George Savage, Benedict Costello, David O'Reilly
-
Patent number: 11044024Abstract: The system of the present invention includes a conductive element, an electronic component, and a partial power source in the form of dissimilar materials. Upon contact with a conducting fluid, a voltage potential is created and the power source is completed, which activates the system. The electronic component controls the conductance between the dissimilar materials to produce a unique current signature. The system can be used in a variety of different applications, including as components of ingestible identifiers, such as may be found in ingestible event markers, e.g., pharma-informatics enabled pharmaceutical compositions.Type: GrantFiled: December 18, 2019Date of Patent: June 22, 2021Assignee: Proteus Digital Health, Inc.Inventors: Mark Zdeblick, Timothy Robertson, Aleksandr Pikelny, Hooman Hafezi
-
Publication number: 20200359933Abstract: Ingestible event markers having high reliability are provided. Aspects of the ingestible event markers include a support, a control circuit, a first electrochemical material, a second electrochemical material and a membrane. In addition, the ingestible event markers may include one or more components that impart high reliability to the ingestible event marker. Further, the ingestible event markers may include an active agent. In some aspects, the active agent, such as a pharmaceutically active agent or a diagnostic agent may be associated with the membrane.Type: ApplicationFiled: December 16, 2019Publication date: November 19, 2020Inventors: Hooman HAFEZI, Kit Yee AU-YEUNG, Robert DUCK, Maria HOLEN, Timothy ROBERTSON, Benedict COSTELLO
-
Publication number: 20200254268Abstract: Transbody communication systems employing communication channels are provided. Various aspects include, for example, an in vivo transmitter to transmit an encoded signal; a transbody functionality module to facilitate communication of the encoded signal; and a receiver to receive the encoded signal. Methods and apparatus are also provided.Type: ApplicationFiled: February 12, 2020Publication date: August 13, 2020Inventors: Timothy ROBERTSON, Kenneth C. CRANDALL, Lawrence W. ARNE